Literature DB >> 19250276

Expression of chemokine receptors CXCR4, CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency.

D Payne1, S Drinkwater, R Baretto, M Duddridge, M J Browning.   

Abstract

The interaction of chemokines and their receptors directs lymphocyte migration, and is involved in the distribution and organization of lymphocytes within lymphoid tissues. We reasoned that abnormal chemokine receptor expression might give rise to defects of lymphocyte migration into and within lymphoid tissues, and consequently be associated with defective antibody production in primary antibody deficiencies. In this study, we have investigated the expression of chemokine receptors CXCR4, CXCR5 and CCR7 on lymphocyte subpopulations (naive and memory B cells; CD4(+) and CD8(+) T cells) in a cohort of patients with primary antibody deficiency (n = 23), and compared these with a group of healthy controls (n = 19). We show that there were significant differences in both the proportions of lymphocytes expressing, and the levels of expression of, specific chemokine receptors on individual lymphocyte subpopulations between patients and controls. Furthermore, these changes appeared more pronounced in patients with more severe antibody deficiency. These data support the hypothesis that abnormal lymphocyte trafficking may be involved in the pathogenesis of primary antibody deficiencies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250276      PMCID: PMC2759473          DOI: 10.1111/j.1365-2249.2009.03889.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo.

Authors:  D A Randolph; G Huang; C J Carruthers; L E Bromley; D D Chaplin
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

4.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

5.  Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Authors:  Karl Balabanian; Angélique Levoye; Lysiane Klemm; Bernard Lagane; Olivier Hermine; Julie Harriague; Françoise Baleux; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

6.  Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.

Authors:  Børre Fevang; Arne Yndestad; Jan K Damås; Vigdis Bjerkeli; Thor Ueland; Are M Holm; Klaus Beiske; Pål Aukrust; Stig S Frøland
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

7.  RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13.

Authors:  Geng-Xian Shi; Kathleen Harrison; Gaye Lynn Wilson; Chantal Moratz; John H Kehrl
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

8.  Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients.

Authors:  Daniele Moratto; Anna Virginia Gulino; Stefania Fontana; Luigi Mori; Silvia Pirovano; Annarosa Soresina; Antonella Meini; Luisa Imberti; Luigi Daniele Notarangelo; Alessandro Plebani; Raffaele Badolato
Journal:  Clin Immunol       Date:  2006-09-07       Impact factor: 3.969

9.  CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.

Authors:  P Schaerli; K Willimann; A B Lang; M Lipp; P Loetscher; B Moser
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.

Authors:  D Breitfeld; L Ohl; E Kremmer; J Ellwart; F Sallusto; M Lipp; R Förster
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  10 in total

1.  The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.

Authors:  Delfien J A Bogaert; Marieke De Bruyne; Veronique Debacker; Pauline Depuydt; Katleen De Preter; Carolien Bonroy; Jan Philippé; Victoria Bordon; Bart N Lambrecht; Tessa Kerre; Andrea Cerutti; Karim Y Vermaelen; Filomeen Haerynck; Melissa Dullaers
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

2.  CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Authors:  Necil Kutukculer; Elif Azarsiz; Guzide Aksu; Neslihan Edeer Karaca
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

Review 3.  Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.

Authors:  Sugandha Saxena; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

4.  The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression.

Authors:  Daniela Frölich; Daniela Blassfeld; Karin Reiter; Claudia Giesecke; Capucine Daridon; Henrik E Mei; Gerd R Burmester; David M Goldenberg; Abdulagabar Salama; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2012-03-09       Impact factor: 5.156

5.  Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen.

Authors:  Shihui Ma; Yingxu Shi; Yakun Pang; Fang Dong; Hui Cheng; Sha Hao; Jing Xu; Xiaofan Zhu; Weiping Yuan; Tao Cheng; Guoguang Zheng
Journal:  J Hematol Oncol       Date:  2014-11-04       Impact factor: 17.388

6.  Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection.

Authors:  Robert M Paris; Lucimar G Milagres; Eirini Moysi; Jason F Okulicz; Brian K Agan; Anu Ganesan; Constantinos Petrovas; Richard A Koup
Journal:  Pathog Immun       Date:  2017-03-14

Review 7.  Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection.

Authors:  Samuel Okurut; David R Boulware; Joseph Olobo; David B Meya
Journal:  Mycoses       Date:  2020-06-19       Impact factor: 4.377

8.  The impact of rare and low-frequency genetic variants in common variable immunodeficiency (CVID).

Authors:  Atil Bisgin; Ozge Sonmezler; Ibrahim Boga; Mustafa Yilmaz
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

9.  Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.

Authors:  Vincent Biajoux; Alexandre Bignon; Christelle Freitas; Valérie Martinez; Marcus Thelen; Guadalupe Lima; Juan Jakez-Ocampo; Dominique Emilie; Luis Llorente; Karl Balabanian
Journal:  J Transl Med       Date:  2012-12-18       Impact factor: 5.531

10.  CD8⁺CXCR5⁺ T cells regulate pathology in the genital tract.

Authors:  Janina Jiang; Cheryl I Champion; Bo Wei; Guangchao Liu; Kathleen A Kelly
Journal:  Infect Dis Obstet Gynecol       Date:  2013-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.